Your browser doesn't support javascript.
loading
Camelid immunoglobulins and nanobody technology.
Muyldermans, S; Baral, T N; Retamozzo, V Cortez; De Baetselier, P; De Genst, E; Kinne, J; Leonhardt, H; Magez, S; Nguyen, V K; Revets, H; Rothbauer, U; Stijlemans, B; Tillib, S; Wernery, U; Wyns, L; Hassanzadeh-Ghassabeh, Gh; Saerens, D.
Affiliation
  • Muyldermans S; Laboratory of Cellular and Molecular Immunology, Department of Molecular and Cellular Interactions, VIB, Vrije Universiteit Brussel, Brussels, Belgium. svmuylde@vub.ac.be
Vet Immunol Immunopathol ; 128(1-3): 178-83, 2009 Mar 15.
Article in En | MEDLINE | ID: mdl-19026455
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins / Camelids, New World / Camelus / Nanotechnology Type of study: Guideline Limits: Animals Language: En Journal: Vet Immunol Immunopathol Year: 2009 Type: Article Affiliation country: Belgium
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins / Camelids, New World / Camelus / Nanotechnology Type of study: Guideline Limits: Animals Language: En Journal: Vet Immunol Immunopathol Year: 2009 Type: Article Affiliation country: Belgium